First-in-human study of first-in-class fatty acid synthase inhibitor, TVB-2640
15th October 2015
Oncology
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given